^
    20h
    MRG003 Combined With Immunotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (clinicaltrials.gov)
    P2, N=30, Not yet recruiting, West China Hospital
    New P2 trial
    |
    Puyouheng (pucotenlimab) • Meiyouheng (becotatug vedotin)
    3d
    Study on the Efficacy and Safety of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Xerostomia after Radiotherapy for Nasopharyngeal Carcinoma (ChiCTR2500107372)
    P2, N=10, Not yet recruiting, Fujian Medical University Union Hospital; Fujian Medical University Union Hospital | Initiation date: Aug 2025 --> Jan 2026
    Trial initiation date
    3d
    A cohort study of antibody-nucleic acid two-step method compared with plasma EBVDNA for nasopharyngeal carcinoma (NPC) screening in high-risk areas of China (ChiCTR2600117497)
    P=N/A, N=0, Not yet recruiting, Fifth Affiliated Hospital, Sun Yat-Sen University; Fifth Affiliated Hospital, Sun Yat-Sen University
    New trial
    3d
    Construction and application of an adaptive radiotherapy triggering timing prediction model for nasopharyngeal carcinoma based on artificial intelligence and research on the interpretability of proteomics (ChiCTR2600116728)
    P=N/A, N=100, Not yet recruiting, The First Hospital of China Medical University; The First Hospital of China Medical University
    New trial
    3d
    Long-term significant efficacy of gemcitabine combined with nedaplatin in persistent refractory nasopharyngeal carcinoma involving the cavernous sinus and distant metastasis:a case report (ChiCTR2500115780)
    P=N/A, N=1, Not yet recruiting, The First Affiliated Hospital of Army Medical University; The First Affiliated Hospital of Army Medical University
    New trial
    |
    gemcitabine • Aqupla (nedaplatin)
    3d
    Effect of Subgingival Scaling on Oral Health in Nasopharyngeal Carcinoma Patients Undergoing Chemoradiotherapy (ChiCTR2500115187)
    P=N/A, N=24, Recruiting, The First Affiliated Hospital of Fujian Medical University; The First Affiliated Hospital of Fujian Medical University
    New trial
    3d
    A Study on the Adherence of Patients with Nasopharyngeal Carcinoma to Oral Capecitabine Based on Digital Nudge (ChiCTR2500114952)
    P=N/A, N=140, Not yet recruiting, Chongqing University Cancer Hospital; Chongqing University Cancer Hospital
    New trial
    |
    capecitabine
    3d
    A prospective, randomized, parallel controlled clinical trial of megestrol acetate oral suspension in patients with locally advanced nasopharyngeal carcinoma (ChiCTR2500114759)
    P=N/A, N=68, Not yet recruiting, Fujian Cancer Hospital; Fujian Cancer Hospital
    New trial
    |
    megestrol • TheraCIM (nimotuzumab)
    3d
    Study on a New Method of VMAT Dose Verification for Nasopharyngeal Carcinoma Based on Multimodal Feature Coupled Diffusion Model (ChiCTR2500113952)
    P=N/A, N=200, Not yet recruiting, Jiangxi Cancer Hospital; Jiangxi Cancer Hospital
    New trial
    3d
    A prediction model for the efficacy of induction chemotherapy in locally advanced nasopharyngeal carcinoma based on the combination of neural networks optimized by ant colony algorithm and MRI radiomics (ChiCTR2500112883)
    P=N/A, N=2118, Completed, Guangxi Medical University Cancer Hospital; Guangxi Medical University Cancer Hospital
    New trial
    3d
    The impact of frailty, malnutrition, and olfactory dysfunction on the prognosis of patients with nasopharyngeal carcinoma osteonecrosis (ChiCTR2500112954)
    P=N/A, N=150, Completed, The Third Affiliated Hospital Sun Yat-sen University; The Third Affiliated Hospital Sun Yat-sen University
    New trial
    3d
    Study on Relationship between T staging and Volume of Nasopharyngeal Carcinoma and the Accuracy of Target Segmentation Using Auto-segmentation Software (ChiCTR2500112413)
    P=N/A, N=54, Not yet recruiting, Affiliated Hospital of Guangdong Medical University; Affiliated Hospital of Guangdong Medical University
    New trial